Robert Torray - Torray Fund Portfolio Performance Analysis (Q3 2026)
Investment performance metrics based on historical 13F filings data.
Data Coverage: June 2013 to September 2026 • Initial Portfolio Value: $0.33B
Performance calculated from first filing in our database. This may not represent the investor's entire career.
Portfolio Growth (Since First Filing)
+0.33B
+100.07%
Winning Positions
+60.29%
164 wins / 272 positions
Average Gain (Winners)
$4.61M
+449.17% avg per position
Active Positions
88
84 losing positions
Portfolio Value Over Time
Total Positions Tracked
272
All holdings over time
Win/Loss Ratio
1.95
164 gains / 84 losses
Active vs. Exited
88 / 184
Current positions / Exited
Position Performance
Performance calculated from first appearance in 13F filings. Initial values represent position value when first tracked, not actual purchase prices.
| Symbol | Company | Sector | Entry | Status | Initial Value | Current Value | Gain/Loss | Return % |
|---|---|---|---|---|---|---|---|---|
| AVGO | Broadcom Inc. | Technology | Sep 2022 | ACTIVE | $1.04M | $41.77M | $40.72M | +3908.32% |
| FMC | FMC Corporation | Basic Materials | Jun 2013 | EXITED | $3.00M | $35.42M | $32.42M | +1081.03% |
| RPRX | Royalty Pharma plc | Healthcare | Dec 2021 | ACTIVE | $5.50M | $32.94M | $27.44M | +499.27% |
| PSX | Phillips 66 | Energy | Jun 2016 | ACTIVE | $474.00K | $27.27M | $26.80M | +5653.63% |
| CVX | Chevron Corporation | Energy | Jun 2013 | ACTIVE | $213.00K | $24.49M | $24.28M | +9,999%+ |
| CEG | Constellation Energy Corporatio | Utilities | Dec 2024 | ACTIVE | $5.39M | $29.55M | $24.16M | +448.29% |
| AMGN | Amgen Inc. | Healthcare | Sep 2017 | ACTIVE | $1.05M | $23.24M | $22.19M | +2109.16% |
| ACN | Accenture plc | Technology | Jun 2013 | ACTIVE | $3.69M | $25.76M | $22.07M | +597.66% |
| PFE | Pfizer, Inc. | Healthcare | Mar 2025 | ACTIVE | $3.37M | $24.65M | $21.27M | +630.50% |
| ABBV | AbbVie Inc. | Healthcare | Jun 2016 | ACTIVE | $560.00K | $21.81M | $21.25M | +3794.70% |
Important Note: Data Limitations
These metrics are based on 13F filing data which has significant limitations:
- Quarterly Snapshots Only: 13F filings show positions at quarter-end, not actual transaction prices
- No Transaction Prices: We cannot determine actual buy/sell prices, only end-of-quarter values
- Performance Estimates: Gains/losses are calculated from first appearance to last update using quarterly values
- Missing Data: Intra-quarter trades, dividends, corporate actions, and exact timing are not captured
- Educational Only: These metrics are estimates for understanding general investment patterns, not actual realized returns
Use these metrics for informational and educational purposes only. They represent broad trends, not precise investment performance.